Skip to content


  • Poster presentation
  • Open Access

Lack of mechanical and thermal allodynia, and thermal hyperalgesia induced by peripheral neuropathic pain in NOS2 knockout mice

BMC Pharmacology20099(Suppl 1):P24

Published: 11 August 2009


  • Neuropathic Pain
  • Wild Type Mouse
  • Sciatic Nerve
  • Thermal Hyperalgesia
  • Thermal Stimulus


Neuropathic pain is a clinical manifestation characterized by the presence of spontaneous pain, hyperalgesia and allodynia. Several works have demonstrated that selective NOS2 inhibitors might reverse the hypersensitivity to pain induced by neuropathy [1, 2]. Although these studies suggest a potential role of NOS2 in the modulation of neuropathic pain, the exact involvement of NOS2 in the development of peripheral neuropathic pain remains unclear. The aim of this study is to investigate the involvement of nitric oxide synthesized by NOS2 in the development and expression of neuropathic pain after total sciatic nerve injury.

Materials and methods

Neuropathic pain induced by the chronic constriction of the sciatic nerve (CCI) was performed in NOS2 knockout (NOS2-KO) mice and their wild type (WT) littermates. The development of mechanical and thermal allodynia, and thermal hyperalgesia was evaluated by using the von Frey filaments, cold plate and plantar tests, respectively. Both, NOS2-KO and WT mice were tested in each paradigm on days 1, 4, 7, 10, 14 and 21 after CCI induction. We used sham-operated NOS2-KO and WT mice as controls.


Pre-surgical tactile and thermal withdrawal thresholds were similar in both genotypes. In WT mice, the chronic constriction of the sciatic nerve led to a neuropathic pain syndrome characterized by a marked and long lasting reduction of the paw withdrawal thresholds to mechanical and thermal stimuli. In contrast, NOS2-KO mice failed to display peripheral nerve injury-induced mechanical and thermal allodynia as well as thermal hyperalgesia. Indeed, significant differences were observed when compared the paw withdrawal thresholds to mechanical and thermal stimuli between the ipsilateral paws of both genotypes (P < 0.001; Student's t-test). As expected, no significant changes in withdrawal thresholds to mechanical and thermal stimuli were seen on the contralateral paw in either WT or NOS2-KO operated mice, as well as on the contralateral and ipsilateral paws of both WT and NOS2-KO sham-operated mice. Although a significant decrease of the thermal withdrawal latencies was observed in NOS2-KO mice when compared the ipsilateral vs. contralateral paw, from day 7 to 21 after CCI (P < 0.05; Student's t-test).


These results indicate that nitric oxide synthesized by NOS2 plays a critical role in the development and expression of peripheral neuropathic pain in mice.



This work was supported by grants from Fondo de Investigación Sanitaria (05/1604) and Fundació La Marató de TV3 (07/0810), Spain.

Authors’ Affiliations

Laboratori de Neurofarmacologia Molecular, Institut de Recerca, Hospital de la Santa Creu i Sant Pau & Institut de Neurociències, Universitat Autònoma de Barcelona, Barcelona, Spain


  1. LaBuda CJ, Koblish M, Tuthill P, Dolle RE, Little PJ: Antinociceptive activity of the selective iNOS inhibitor AR-C102222 in rodent models of inflammatory, neuropathic and post-operative pain. Eur J Pain. 2006, 10: 505-512. 10.1016/j.ejpain.2005.07.004.View ArticlePubMedGoogle Scholar
  2. DeAlba J, Clayton NM, Collins SD, Colthup P, Chessell I, Knowles RG: GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain. Pain. 2006, 120: 170-181. 10.1016/j.pain.2005.10.028.View ArticleGoogle Scholar


© Hervera et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.